| Committee opinion. Induction of labor for vaginal birth after cesarean delivery. | |
| | |
MedLine Citation:
|
PMID: 12039139 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A recent population-based study of vaginal birth after cesarean delivery (VBAC) attempts observed uterine rupture rates of 24.5 per 1,000 with prostaglandin-induced labor, while the uterine rupture rates with spontaneous labor and labor induced without prostaglandins were lower (5.2/1,000 and 7.71/1,000 respectively). The authors did not confirm the diagnoses by examining individual medical records, so the actual incidence of uterine rupture may have been overstated. Despite this limitation, the Committee on Obstetric Practice concludes that the risk of uterine rupture during VBAC attempts is substantially increased with the use of various prostaglandin cervical ripening agents for the induction of labor, and their use for this purpose is discouraged. |
| | |
Authors:
|
|
Related Documents
:
|
6742019 - The risks of amniocentesis in the management of premature rupture of the membranes. 21381589 - Klebsiella osteomyelitis of the right humerus involving the right shoulder joint in an ... 17273389 - Teaching normal birth interactively. 1617879 - Home uterine activity monitoring. 14710099 - Does cerclage location influence perinatal outcome? 4037009 - Preterm rupture of the membranes: combination therapy. 21218679 - Effectiveness of cheek and jaw support to improve feeding performance of preterm infants. 7463279 - Percutaneous transhepatic cholangiodrainage after hepatic portoenterostomy for biliary ... 6742019 - The risks of amniocentesis in the management of premature rupture of the membranes. |
Publication Detail:
|
Type: Guideline; Journal Article; Practice Guideline |
Journal Detail:
|
Title: Obstetrics and gynecology Volume: 99 ISSN: 0029-7844 ISO Abbreviation: Obstet Gynecol Publication Date: 2002 Apr |
Date Detail:
|
Created Date: 2002-05-31 Completed Date: 2002-09-03 Revised Date: 2009-10-26 |
Medline Journal Info:
|
Nlm Unique ID: 0401101 Medline TA: Obstet Gynecol Country: United States |
Other Details:
|
Languages: eng Pagination: 679-80 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Female Humans Labor, Induced / methods*, standards* Misoprostol / contraindications Pregnancy Prostaglandins / contraindications Risk Factors Uterine Rupture / prevention & control Vaginal Birth after Cesarean / methods*, standards* |
| Chemical | |
Reg. No./Substance:
|
0/Prostaglandins; 59122-46-2/Misoprostol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Endometrial thickness as a test for endometrial cancer in women with postmenopausal vaginal bleeding...
Next Document: Fidarestat (SNK-860), a potent aldose reductase inhibitor, normalizes the elevated sorbitol accumula...